The Food and Drug Administration’s (FDA) integration of artificial intelligence (AI) into drug development and manufacturing is expanding rapidly, but…
A recent Office of Inspector General (OIG) report investigating the impact of vertical integration in Medicare Part D highlights significant…
On May 19, Governor Spanberger vetoed H.B.483/S.B.271, which would have established a Prescription Drug Affordability Board (PDAB) in Virginia. Aimed…
Aimed Alliance has released a new resource explaining recent federal reforms to pharmacy benefit managers (PBMs) under the Consolidated Appropriations…
On May 19, Governor Spanberger vetoed H.B.483/S.B.271, which would have established a Prescription Drug Affordability Board (PDAB) in Virginia. Aimed…
On March 13, 2026, Aimed Alliance commented on the 2027 Notice of Benefit and Payment Parameters (2027 NBPP). In its…
On March 19, 2026, Aimed Alliance provided testimony to the New Jersey Prescription Drug Affordability Council, which is developing legislative…
On March 16, Aimed Alliance submitted a comment on the proposed settlement between the Federal Trade Commission and Express Scripts,…
On March 18, 2026, Aimed Alliance submitted comments to the Health Care Availability & Accessibility Committee urging caution against Illinois…
On March 13, 2026, Aimed Alliance sent a letter to Governor Abigail Spanberger urging amendments to Virginia’s House Bill 483,…